News
Click here for news in Danish.
August 05, 2020 | Press Releases
Bavarian Nordic Announces the Launch of Distribution and Marketing of RabAvert® in the U.S. Supported by a U.S. Commercial Team July 22, 2020 | Company Announcements
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 VaccineJuly 03, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchJuly 01, 2020 | Company Announcements
Bavarian Nordic Announces European Marketing Authorization for Ebola VaccineJune 18, 2020 | Company Announcements
Bavarian Nordic and Valneva Announce Marketing and Distribution Partnership June 12, 2020 | Company Announcements
Bavarian Nordic to Manufacture Additional Ebola Vaccines for JanssenJune 12, 2020 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held June 12, 2020June 08, 2020 | Company Announcements
Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine May 29, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMay 29, 2020 | Company Announcements
Bavarian Nordic Announces that Janssen has Received Positive CHMP Opinion for its Investigational Preventative Ebola Vaccine RegimenMay 25, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMay 25, 2020 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseMay 20, 2020 | Company Announcements
Bavarian Nordic A/S – Notice Convening Annual General MeetingMay 14, 2020 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Three Months of 2020May 06, 2020 | Company Announcements
Bavarian Nordic Enters Agreement with AdaptVac to Advance COVID-19 Vaccine ProgramMay 01, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMay 01, 2020 | Company Announcements
Bavarian Nordic Awards Restricted Stock Units to New Member of Executive Management April 30, 2020 | Company Announcements
Bavarian Nordic Announces a New Order for JYNNEOS Smallpox Vaccine from the U.S. Government Potentially Worth USD 200 MillionApril 27, 2020 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchApril 03, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Citigroup IncApril 02, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Nordea Bank Abp April 02, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from ATPApril 01, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Citigroup IncMarch 31, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Nordea Bank Abp March 30, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Johnson & Johnson Innovation – JJDC, Inc.